These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

911 related items for PubMed ID: 33346078

  • 1. Synergistic effect of two antimicrobial peptides, Nisin and P10 with conventional antibiotics against extensively drug-resistant Acinetobacter baumannii and colistin-resistant Pseudomonas aeruginosa isolates.
    Jahangiri A, Neshani A, Mirhosseini SA, Ghazvini K, Zare H, Sedighian H.
    Microb Pathog; 2021 Jan; 150():104700. PubMed ID: 33346078
    [Abstract] [Full Text] [Related]

  • 2. Highly Synergistic Effects of Melittin with Conventional Antibiotics Against Multidrug-Resistant Isolates of Acinetobacter baumannii and Pseudomonas aeruginosa.
    Akbari R, Hakemi-Vala M, Pashaie F, Bevalian P, Hashemi A, Pooshang Bagheri K.
    Microb Drug Resist; 2019 Mar; 25(2):193-202. PubMed ID: 30281385
    [Abstract] [Full Text] [Related]

  • 3. In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units.
    Timurkaynak F, Can F, Azap OK, Demirbilek M, Arslan H, Karaman SO.
    Int J Antimicrob Agents; 2006 Mar; 27(3):224-8. PubMed ID: 16464562
    [Abstract] [Full Text] [Related]

  • 4. Synergistic activities of ceftazidime-avibactam in combination with different antibiotics against colistin-nonsusceptible clinical strains of Pseudomonas aeruginosa.
    Mataraci Kara E, Yilmaz M, İstanbullu Tosun A, Özbek Çelik B.
    Infect Dis (Lond); 2020 Sep; 52(9):616-624. PubMed ID: 32427010
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. In Vitro Synergistic Effects of Antimicrobial Combinations on Extensively Drug-Resistant Pseudomonas aeruginosa and Acinetobacter baumannii Isolates.
    Lee H, Roh KH, Hong SG, Shin HB, Jeong SH, Song W, Uh Y, Yong D, Lee K.
    Ann Lab Med; 2016 Mar; 36(2):138-44. PubMed ID: 26709261
    [Abstract] [Full Text] [Related]

  • 7. Effect of combined colistin and meropenem against meropenem resistant Acinetobacter baumannii and Pseudomonas aeruginosa by checkerboard method: A cross sectional analytical study.
    Gunalan A, Sarumathi D, Sastry AS, Ramanathan V, Rajaa S, Sistla S.
    Indian J Pharmacol; 2021 Mar; 53(3):207-212. PubMed ID: 34169905
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. In Vitro Synergistic Activity of Antimicrobial Agents in Combination against Clinical Isolates of Colistin-Resistant Acinetobacter baumannii.
    Bae S, Kim MC, Park SJ, Kim HS, Sung H, Kim MN, Kim SH, Lee SO, Choi SH, Woo JH, Kim YS, Chong YP.
    Antimicrob Agents Chemother; 2016 Nov; 60(11):6774-6779. PubMed ID: 27600048
    [Abstract] [Full Text] [Related]

  • 10. In vitro activities of ceftazidime/avibactam alone or in combination with antibiotics against multidrug-resistant Acinetobacter baumannii isolates.
    Mataracı Kara E, Yılmaz M, Özbek Çelik B.
    J Glob Antimicrob Resist; 2019 Jun; 17():137-141. PubMed ID: 30576787
    [Abstract] [Full Text] [Related]

  • 11. Antibacterial Properties and Efficacy of LL-37 Fragment GF-17D3 and Scolopendin A2 Peptides Against Resistant Clinical Strains of Staphylococcus aureus, Pseudomonas aeruginosa, and Acinetobacter baumannii In Vitro and In Vivo Model Studies.
    Farzi N, Oloomi M, Bahramali G, Siadat SD, Bouzari S.
    Probiotics Antimicrob Proteins; 2024 Jun; 16(3):796-814. PubMed ID: 37148452
    [Abstract] [Full Text] [Related]

  • 12. In vitro activity of colistin plus sulbactam against extensive-drug-resistant Acinetobacter baumannii by checkerboard method.
    Thamlikitkul V, Tiengrim S.
    J Med Assoc Thai; 2014 Mar; 97 Suppl 3():S1-6. PubMed ID: 24772574
    [Abstract] [Full Text] [Related]

  • 13. Antimicrobial susceptibility patterns of multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii against carbapenems, colistin, and tigecycline.
    Somily AM, Absar MM, Arshad MZ, Al Aska AI, Shakoor ZA, Fatani AJ, Siddiqui YM, Murray TS.
    Saudi Med J; 2012 Jul; 33(7):750-5. PubMed ID: 22821309
    [Abstract] [Full Text] [Related]

  • 14. In vitro synergistic effect of colistin and ampicillin/sulbactam with several antibiotics against clinical strains of multi-drug resistant Acinetobacter baumannii.
    Shafiee F, Naji Esfahani SS, Hakamifard A, Soltani R.
    Indian J Med Microbiol; 2021 Jul; 39(3):358-362. PubMed ID: 33906750
    [Abstract] [Full Text] [Related]

  • 15. Synergistic effect between nisin and polymyxin B against pandrug-resistant and extensively drug-resistant Acinetobacter baumannii.
    Thomas VM, Brown RM, Ashcraft DS, Pankey GA.
    Int J Antimicrob Agents; 2019 May; 53(5):663-668. PubMed ID: 30880230
    [Abstract] [Full Text] [Related]

  • 16. Synergistic activity profile of an antimicrobial peptide against multidrug-resistant and extensively drug-resistant strains of Gram-negative bacterial pathogens.
    Pollini S, Brunetti J, Sennati S, Rossolini GM, Bracci L, Pini A, Falciani C.
    J Pept Sci; 2017 Apr; 23(4):329-333. PubMed ID: 28176481
    [Abstract] [Full Text] [Related]

  • 17. CSA-131, a ceragenin active against colistin-resistant Acinetobacter baumannii and Pseudomonas aeruginosa clinical isolates.
    Vila-Farrés X, Callarisa AE, Gu X, Savage PB, Giralt E, Vila J.
    Int J Antimicrob Agents; 2015 Nov; 46(5):568-71. PubMed ID: 26395218
    [Abstract] [Full Text] [Related]

  • 18. In vitro effects of sulbactam combinations with different antibiotic groups against clinical Acinetobacter baumannii isolates.
    Deveci A, Coban AY, Acicbe O, Tanyel E, Yaman G, Durupinar B.
    J Chemother; 2012 Oct; 24(5):247-52. PubMed ID: 23182043
    [Abstract] [Full Text] [Related]

  • 19. Synergistic activities of colistin combined with other antimicrobial agents against colistin-resistant Acinetobacter baumannii clinical isolates.
    Almutairi MM.
    PLoS One; 2022 Oct; 17(7):e0270908. PubMed ID: 35830449
    [Abstract] [Full Text] [Related]

  • 20. In vitro antimicrobial synergy of colistin with rifampicin and carbapenems against colistin-resistant Acinetobacter baumannii clinical isolates.
    Hong DJ, Kim JO, Lee H, Yoon EJ, Jeong SH, Yong D, Lee K.
    Diagn Microbiol Infect Dis; 2016 Oct; 86(2):184-9. PubMed ID: 27475960
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 46.